Ticker

BMY

Bristol Myers Squibb

8 catalysts on file

BMY

Bristol Myers Squibb

Phase 3 AI-extracted

Camzyos

obstructive hypertrophic cardiomyopathy

221d ago Jan 12, 2026

SEC 8-K verified 2mo ago

Countdown card →

BMY

Bristol Myers Squibb

Approval Confirmed

Sotyktu

psoriasis

168d ago Mar 6, 2026

SEC 8-K verified 2mo ago

Countdown card →

BMY

Bristol Myers Squibb

Phase 2 Confirmed

mezigdomide

Multiple Myeloma

165d ago Mar 9, 2026

SEC 8-K verified 2mo ago

Countdown card →

BMY

Bristol Myers Squibb

Approval Confirmed

Opdivo

Hodgkin Lymphoma

154d ago Mar 20, 2026

SEC 8-K verified 2mo ago

Countdown card →

BMY

Bristol Myers Squibb

Phase 2 Confirmed

Cobenfy

Schizophrenia

146d ago Mar 28, 2026

SEC 8-K verified 2mo ago

Countdown card →

BMY

Bristol Myers Squibb

Phase 2 Confirmed

Camzyos

Hypertrophic Cardiomyopathy

145d ago Mar 29, 2026

SEC 8-K verified 2mo ago

Countdown card →

BMY

Bristol Myers Squibb

PDUFA AI-extracted

Opdivo

previously untreated Stage III or IV classical Hodgkin Lymphoma

135d ago Apr 8, 2026

SEC 8-K verified 2mo ago

Countdown card →

BMY

Bristol-Myers Squibb

Phase 3 Estimated

BMS-986278

Idiopathic Pulmonary Fibrosis

T-minus 46 days Oct 6, 2026

ClinicalTrials.gov verified 2mo ago

Countdown card →